Baseline characteristics of patients
| Total | |
| N=60 | |
| Sociodemographics | |
| Age—Mean (SD) | 63.50 (11.65) |
| Gender—N (%) | |
| Female | 27 (45%) |
| Comorbidities—N (%) | |
| Hypertension | 47 (78%) |
| Diabetes | 41 (68%) |
| Dyslipidaemia | 52 (87%) |
| Symptoms—N (%) | |
| Chest pain or shortness of breath | 31 (52%) |
| Medication—N (%) | |
| Aspirin/Clopidogrel | 50 (83%) |
| Statin | 50 (83%) |
| ACE/ARB | 39 (65%) |
| Beta Blockers | 46 (77%) |
| Calcium Channel Blockers | 25 (42%) |
| Study quality—N (%) | |
| Excellent | 20 (33%) |
| Good | 30 (50%) |
| Fair | 10 (17%) |
| CCTA—N (%) | |
| CCTA CAD-RAD | |
| CAD-RAD 0 | 13 (22%) |
| CAD-RAD 1/2 | 24 (40%) |
| CAD-RAD 3 | 11 (18%) |
| CAD-RAD 4A | 7 (12%) |
| CAD-RAD 4B | 5 (8%) |
| CCTA obstructive stenosis | 11 (20%) |
| CCTA multivessel disease | 5 (8%) |
| Plaque burden—Mean (SD) | |
| Total plaque segment involvement score | 4.60 (4.09) |
| Calcified plaque segment involvement score | 1.95 (2.91) |
| Mixed plaque segment involvement score | 2.05 (3.06) |
| Non-calcified plaque segment involvement score | 0.60 (1.34) |
| FFRCT—N (%) | |
| FFRCT <0.80 on any proximal/mid/distal segment | 28 (47%) |
| Left main FFRCT<0.8 | 1 (2%) |
| Major LAD segment FFRCT <0.80 | 18 (30%) |
| Major LCX segment FFRCT <0.80 | 14 (23%) |
| Major RCA segment FFRCT <0.80 | 14 (24%) |
CAD-RAD, Cardiovascular Computed Tomography Coronary Artery Disease Reporting & Data System; CCTA, coronary CT angiography; FFR, fractional flow reserve; LAD, left anterior descending; LCX, left circumflex; RCA, right coronary artery.